Product NDC: | 55154-5722 |
Proprietary Name: | Glycopyrrolate |
Non Proprietary Name: | Glycopyrrolate |
Active Ingredient(s): | .2 mg/mL & nbsp; Glycopyrrolate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-5722 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA089335 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111025 |
Package NDC: | 55154-5722-5 |
Package Description: | 5 VIAL, SINGLE-DOSE in 1 BAG (55154-5722-5) > 1 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 55154-5722-5 |
Proprietary Name | Glycopyrrolate |
Package Description | 5 VIAL, SINGLE-DOSE in 1 BAG (55154-5722-5) > 1 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 55154-5722 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Glycopyrrolate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20111025 |
Marketing Category Name | ANDA |
Labeler Name | Cardinal Health |
Substance Name | GLYCOPYRROLATE |
Strength Number | .2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |